Operating Lease, Right-of-Use Asset of Repare Therapeutics Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Repare Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Repare Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Repare Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$2,473,000 -100% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $629,000 -$1,566,000 -71% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $1,365,000 -$1,398,000 -51% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $1,924,000 -$1,402,000 -42% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $2,473,000 -$1,410,000 -36% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $2,195,000 -$2,239,000 -50% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $2,763,000 -$2,213,000 -44% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $3,326,000 -$2,045,000 -38% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $3,883,000 -$2,021,000 -34% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $4,434,000 -$2,022,000 -31% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $4,976,000 -$2,027,000 -29% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $5,371,000 -$2,120,000 -28% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $5,904,000 -$1,349,000 -19% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $6,456,000 +$1,825,000 +39% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $7,003,000 +$2,700,000 +63% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $7,491,000 +$2,817,000 +60% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $7,253,000 +$2,231,000 +44% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $4,631,000 +$3,902,000 +535% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $4,303,000 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $4,674,000 +$3,640,000 +352% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $5,022,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $729,000 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q4 2019 $1,034,000 31 Dec 2019 10-K 04 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.